• Home
  • Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies.

Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies.

Author List
Liou A, Wahlstrom JT, Dvorak CC, Horn BN
Publication
Bone marrow transplantation
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1210369
Publication Year
2017
PubMed ID
28394367
Publication Title
Liou A, Wahlstrom JT, Dvorak CC, Horn BN. Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies. Bone Marrow Transplant. 2017 07; 52(7):1057-1059.